ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

UMN Uramin Inc

389.00
0.00 (0.00%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Uramin Inc LSE:UMN London Ordinary Share VGG9298V1067 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 389.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Block Admission Application

01/06/2007 3:00pm

UK Regulatory


RNS Number:6328X
UraMin Inc
01 June 2007

1 June 2007



                                  UraMin Inc.
                          ("UraMin" or "the Company")

                                Block Listing


                  Block Admission Application - Clarification


UraMin Inc wishes to clarify the announcement released yesterday regarding the
application to the London Stock Exchange for Block Admission to AIM of certain
shares.


The announcement made yesterday related to the options currently outstanding
under the Company's share option scheme. The Company wishes to clarify that it
has received no indication of the exercise of any share options covered by the
application, nor is it currently contemplating the grant of any further options,
under the scheme or otherwise. The grants of all the options to which
yesterday's announcement relates have previously been announced to the market,
either in the Company's admission document dated 13 April 2006 or in subsequent
RNS announcements. UraMin's application for Block Admission of the shares which
may be issued in the future following the exercise of the options granted under
the share option scheme is intended merely to simplify the administration of the
share option scheme and thereby reduce its compliance costs.


The Block Admission procedure on AIM is a means whereby a company which expects
to issue shares on a regular basis may seek approval for their admission to AIM
in advance of their issue. In the absence of a Block Admission arrangement
individual applications for admission to AIM need to be made on the occasion of
each allotment. The Block Admission procedure is commonly used by AIM companies
in connection with share option schemes, warrants or other convertible
securities where the timing of allotments is not under the control of the AIM
company itself but of the holders of the convertible securities. Companies
taking advantage of the Block Admission procedure are required at least once
every six months to make an announcement of the shares issued under the Block
Admission procedure.



UraMin already has such a procedure in place for its warrants issued in 2005.



For further information:



Ian Stalker, Chief Executive Officer
Neil Herbert, Finance Director
Tel: +27 (0)11 783 5056


Nominated Advisor
Canaccord Adams
Robin Birchall
Tel: +44 (0) 20 7050 6500



UraMin (www.uramin.com) was established in 2005 to acquire and develop mineral
properties, predominantly uranium. The Company currently has working capital of
approximately US$300 million and a market capitalization of approximately US$1.9
billion on an undiluted basis. UraMin (www.uramin.com) is traded on the
Alternative Investment Market of the London Stock Exchange plc and the Toronto
Stock Exchange under the symbol UMN.



UraMin is currently focusing on the development of its advanced stage
exploration projects at Trekkopje in Namibia, Bakouma in the Central African
Republic and Ryst Kuil in South Africa. Through a South African joint venture,
UraMin also enjoys additional prospecting license applications for important
uranium deposits in the Karoo, South Africa. No assurance can be given that
remaining applications for prospecting licences will be successful.





Forward-Looking Statements:



This press release contains statements that are "forward-looking". Generally,
the words "expect," "intend," "estimate," "will" and similar expressions
identify forward-looking statements. By their very nature, forward-looking
statements are subject to known and unknown risks and uncertainties that may
cause our actual results, performance or achievements, or that of our industry,
to differ materially from those expressed or implied in any of our
forward-looking statements. Statements in this press release regarding the
Company's business or proposed business, which are not historical facts, are
"forward looking" statements that involve risks and uncertainties, such as
estimates and statements that describe the Company's future plans, objectives or
goals, including words to the effect that the Company or management expects a
stated condition or result to occur. Since forward-looking statements address
future events and conditions, by their very nature, they involve inherent risks
and uncertainties. Actual results in each case could differ materially from
those currently anticipated in such statements.



Investors are cautioned not to place undue reliance on forward-looking
statements, which speak only as of the date they are made.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

LISKGGGVZMRGNZM

1 Year Uramin Chart

1 Year Uramin Chart

1 Month Uramin Chart

1 Month Uramin Chart

Your Recent History

Delayed Upgrade Clock